Fc-engineered antibody therapeutics with improved efficacy against COVID-19.

导出 LinkOut

翻译打印收藏纠错

第一作者： Rachel,Yamin

第一单位： Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.

作者： Rachel,Yamin ^[1] ; Andrew T,Jones ^[1] ; Hans-Heinrich,Hoffmann ^[2] ; Kevin S,Kao ^[1] ; Rebecca L,Francis ^[1] ; Timothy P,Sheahan ^[3] ; Ralph S,Baric ^[4] ; Charles M,Rice ^[2] ; Jeffrey V,Ravetch ^[1] ; Stylianos,Bournazos ^[1]

作者单位： Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY. ^[1] Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY. ^[2] Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ^[3] Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.;Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ^[4]

DOI 10.21203/rs.3.rs-555612/v1

PMID 34075373

发布时间 2024-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Research square

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Fc-engineered antibody therapeutics with improved efficacy against COVID-19.

Research square

相似文献

Research square

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Fc-engineered antibody therapeutics with improved efficacy against COVID-19.

Research square

相似文献

Research square

相关期刊

检索历史清除